Santero Therapeutics

Charleroi, Belgium

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

$8.6M raised

Jun 2023

Series A

Biotechnology Health Care Therapeutics

Top Investors

Newton Biocapital SFPIM Sambrinvest S.R.I.W.Pierre Drion

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Santero Therapeutics

How much funding has Santero Therapeutics raised?

Santero Therapeutics has raised $8.6M in total funding. The most recent round was Series A. The last funding was announced in June 2023.

Who are Santero Therapeutics's investors?

Santero Therapeutics's investors include Newton Biocapital, SFPIM, Sambrinvest, S.R.I.W., Pierre Drion.

Where is Santero Therapeutics headquartered?

Santero Therapeutics is headquartered in Charleroi, Belgium.

What does Santero Therapeutics do?

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

What stage is Santero Therapeutics at?

Santero Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 7, 2023.

MLA

"Santero Therapeutics — Funding & Investors." VCBacked, June 7, 2023, https://www.vcbacked.co/company/santero-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2023). Santero Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/santero-therapeutics

Wikipedia (cite web)

{{cite web |title=Santero Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/santero-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 7, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K